Hast R - Search Results

1

Persistent malignant stem cells in del(5q) myelodysplasia in remission.

Tehranchi R, Woll PS, Anderson K, Buza-Vidas N, Mizukami T, Mead AJ, Astrand-Grundström I, Strömbeck B, Horvat A, Ferry H, Dhanda RS, Hast R, Rydén T, Vyas P, Göhring G, Schlegelberger B, Johansson B, Hellström-Lindberg E, List A, Nilsson L, Jacobsen SE. Tehranchi R, et al. Among authors: hast r. N Engl J Med. 2010 Sep 9;363(11):1025-37. doi: 10.1056/NEJMoa0912228. N Engl J Med. 2010. PMID: 20825315 Free article.

2

The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.

Nilsson L, Edén P, Olsson E, Månsson R, Astrand-Grundström I, Strömbeck B, Theilgaard-Mönch K, Anderson K, Hast R, Hellström-Lindberg E, Samuelsson J, Bergh G, Nerlov C, Johansson B, Sigvardsson M, Borg A, Jacobsen SE. Nilsson L, et al. Among authors: hast r. Blood. 2007 Oct 15;110(8):3005-14. doi: 10.1182/blood-2007-03-079368. Epub 2007 Jul 6. Blood. 2007. PMID: 17616640 Free article.

3

Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.

Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE. Nilsson L, et al. Among authors: hast r. Blood. 2002 Jul 1;100(1):259-67. doi: 10.1182/blood-2001-12-0188. Blood. 2002. PMID: 12070035 Free article.

4

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.

Nilsson L, Astrand-Grundström I, Arvidsson I, Jacobsson B, Hellström-Lindberg E, Hast R, Jacobsen SE. Nilsson L, et al. Among authors: hast r. Blood. 2000 Sep 15;96(6):2012-21. Blood. 2000. PMID: 10979941 Free article.

5

TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.

Jädersten M, Saft L, Smith A, Kulasekararaj A, Pomplun S, Göhring G, Hedlund A, Hast R, Schlegelberger B, Porwit A, Hellström-Lindberg E, Mufti GJ. Jädersten M, et al. Among authors: hast r. J Clin Oncol. 2011 May 20;29(15):1971-9. doi: 10.1200/JCO.2010.31.8576. Epub 2011 Apr 25. J Clin Oncol. 2011. PMID: 21519010

6

Fluorescence in situ hybridization for the study of cell lineage involvement in myelodysplastic syndromes with chromosome 5 anomalies.

Anderson K, Arvidsson I, Jacobsson B, Hast R. Anderson K, et al. Among authors: hast r. Cancer Genet Cytogenet. 2002 Jul 15;136(2):101-7. doi: 10.1016/s0165-4608(02)00515-0. Cancer Genet Cytogenet. 2002. PMID: 12237232

7

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.

Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fadeel B, Forsblom AM, Travaglino E, Samuelsson J, Hast R, Nilsson L, Cazzola M, Wibom R, Hellström-Lindberg E. Tehranchi R, et al. Among authors: hast r. Blood. 2005 Jul 1;106(1):247-53. doi: 10.1182/blood-2004-12-4649. Epub 2005 Mar 8. Blood. 2005. PMID: 15755901 Free article.

8

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.

Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E. Broliden PA, et al. Among authors: hast r. Haematologica. 2006 May;91(5):667-70. Haematologica. 2006. PMID: 16670072 Clinical Trial.

9

Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes.

Widell S, Hellström-Lindberg E, Kock Y, Lindberg M, Ost A, Hast R. Widell S, et al. Among authors: hast r. Am J Hematol. 1995 Jun;49(2):115-20. doi: 10.1002/ajh.2830490204. Am J Hematol. 1995. PMID: 7771462

10

Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.

Tehranchi R, Fadeel B, Schmidt-Mende J, Forsblom AM, Emanuelsson E, Jadersten M, Christensson B, Hast R, Howe RB, Samuelsson J, Zhivotovsky B, Hellström-Lindberg E. Tehranchi R, et al. Among authors: hast r. Clin Cancer Res. 2005 Sep 1;11(17):6291-9. doi: 10.1158/1078-0432.CCR-04-1850. Clin Cancer Res. 2005. PMID: 16144933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page